Intercure annual total assets
2019
2020
2021
2022
2023
2024
2025
Intercure Total Assets Growth & History (INCR)
Intercure's total assets was ₪690.6M for fiscal 2025.
View full Intercure company overviewIntercure annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | ₪690.6M | −₪72.0M | −9.44% |
| 2024 | 2024-12-31 | ₪762.6M | −₪24.0M | −3.06% |
| 2023 | 2023-12-31 | ₪786.6M | −₪171.4M | −17.89% |
| 2022 | 2022-12-31 | ₪958.0M | ₪261.5M | +37.54% |
| 2021 | 2021-12-31 | ₪696.5M | ₪370.3M | +113.49% |
| 2020 | 2020-12-31 | ₪326.3M | ₪44.0M | +15.60% |
| 2019 | 2019-12-31 | ₪282.2M | — | — |
Intercure quarterly total assets
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | ₪690.6M | −₪72.0M | −9.44% |
| Q4 2024 | 2024-12-31 | ₪762.6M | −₪24.0M | −3.06% |
| Q4 2023 | 2023-12-31 | ₪786.6M | −₪171.4M | −17.89% |
| Q4 2022 | 2022-12-31 | ₪958.0M | ₪261.5M | +37.54% |
| Q4 2021 | 2021-12-31 | ₪696.5M | ₪370.3M | +113.49% |
| Q4 2020 | 2020-12-31 | ₪326.3M | — | — |
Intercure total assets trends
Over the last five fiscal years, Intercure's total assets increased from ₪326.3M to ₪690.6M, a change of ₪364.3M. The latest reported quarter, Q4 2025, shows ₪690.6M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intercure source filings ↗Community posts
InterCure resolves Nasdaq minimum-bid-price deficiency
InterCure ($INCR) received written confirmation that it has regained compliance with Nasdaq’s minimum-bid-price requirement. Its shares had closed at or above $1 for ten consecutive business days, allowing Nasdaq to close the specific defic ...